🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study examines two doses of Ranibizumab (0.5mg and 1.0mg) for the trea...
Status
Completed
Location
South Coast Retina
Start Date
2011-11
Trial ID
NCT01471691
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of MW02 ver...
Status
Unknown
Location
West China Hospital of Sichuan University
Start Date
2021-05-07
Trial ID
NCT05297292
Diabetic maculopathy is the leading cause of visual impairment in the worki...
Status
Unknown
Location
Rudolf Foundation Clinic
Start Date
2008-05
Trial ID
NCT00885794
Treatments Being Tested
Idiopathic Parafoveal Telangiectasia (IPT) \[also known as Idiopathic Perif...
Status
Completed
Location
Eye Center of Northern Colorado
Start Date
2010-10
Trial ID
NCT01205035
Treatments Being Tested
The purpose of this study is to compare the safety and effectiveness of thr...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00557791
Treatments Being Tested
Evaluation of Dosing Interval of Higher Doses of Ranibizumab for patients w...
Status
Completed
Location
Tennessee Retina, P.C.
Start Date
2007-09
Trial ID
NCT00533520
Treatments Being Tested
This is a 24-month study of ranibizumab (2.0 mg and 1.0 mg) in subjects wit...
Status
Completed
Location
Retina Consultants of Hawaii
Start Date
2010-11
Trial ID
NCT01884597
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of Ran...
Status
Completed
Location
Long Island Vitreoretinal Consultants
Start Date
2007-03
Trial ID
NCT00440609
Treatments Being Tested